HolmesC.J., ShockleyT.R.Strategies to reduce glucose exposure in peritoneal dialysis patients.Perit Dial Int2000; 20(Suppl 2): S37–41.
2.
HolmesC., MujaisS.Glucose sparing in peritoneal dialysis: implications and metrics.Kidney Int Suppl2006; 105: S104–9.
3.
DaviesS.J., PhillipsL., NaishP.F., RussellG.I.Peritoneal glucose exposure in changes in membrane solute transport with time in peritoneal dialysis.J Am Soc Nephrol2001; 12: 1046–51.
4.
BredieS.J., BoschF.H., DemackerP.N., StalenhoefA.F., van LeusenR.Effects of peritoneal dialysis with an overnight icodextrin dwell on parameters of glucose and lipid metabolism.Perit Dial Int2001; 21: 275–81.
5.
FreidaP., WilkieM., JenkinsS., DallasF., IssadB.Contribution of combined crystalloid and colloid osmosis to fluid and sodium management in peritoneal dialysis.Kidney Int Suppl2008; 108: S102–11.
6.
PeersE.Icodextrin plus glucose combination for use in CAPD.Perit Dial Int1997; 17(Suppl 2): S102–11.
JenkinsS.B., WilkieM.E.An exploratory study of a novel peritoneal combination dialysate (1.36% glucose/7.5% icodextrin), demonstrating improved ultrafiltration compared to either component studied alone.Perit Dial Int2003; 23: 475–80.
9.
DallasF., JenkinsF.B., WilkieM.E.Enhanced ultrafiltration using 7.5% icodextrin/1.36% glucose combination dialysate: a pilot study.Perit Dial Int2004; 24: 542–6.
10.
FreidaP., GalachM., Divino FilhoJ.C., WeryinskiA., LindholmB.Combination of crystalloid (glucose) and colloid (icodextrin) osmotic agents markedly enhances peritoneal fluid and solute transport during the long peritoneal dialysis dwell.Perit Dial Int2007; 27: 267–76.
11.
FreidaP., IssadB., DratwaM., LobbedezT., WuL., LeypoldtJ.A combined crystalloid and colloid PD solution as a glucose-sparing strategy for volume control in high-transport APD patients: a prospective multicenter study.Perit Dial Int2009; 29: 433–42.
12.
KoningsC.J., KoomanJ.P., GladziwaU., van der SandeF.M., LeunissenK.M.A decline in residual glomerular filtration during the use of icodextrin may be due to underhydration.Kidney Int2005; 67: 1190–1.
13.
DaviesS., CarlssonO., SimonsenO., JohanssonA.C., VenturoliD., LedeboI.The effects of low-sodium peritoneal dialysis fluids on blood pressure, thirst and volume status.Nephrol Dial Transplant2009; 24: 1609–17.
14.
SavT., OymakO., InancM.T., DoganA., TokgazB., UtasC.Effects of twice-daily icodextrin administration on blood pressure and left ventricular mass in patients on continuous ambulatory peritoneal dialysis.Perit Dial Int2009; 29: 443–9.
15.
GokalR., MoberlyJ., Lindholm, MujaisS.Metabolic and laboratory effects of icodextrin.Kidney Int Suppl2002; 81: S62–71.
